Thierry Bordet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD).
Journal: Cell death & disease
Published: January 17, 2025
Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.
Journal: International journal of molecular sciences
Published: September 20, 2022
Anti-TNF-α in the treatment of non-infectious uveitis
Journal: Medecine sciences : M/S
Published: October 07, 2020
Transferrin Non-Viral Gene Therapy for Treatment of Retinal Degeneration.
Journal: Pharmaceutics
Published: August 07, 2020
Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives.
Journal: Drug discovery today
Published: December 01, 2018
Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome.
Journal: Molecular therapy. Methods & clinical development
Published: October 09, 2018
Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 27, 2018
TRO40303 Ameliorates Alcohol-Induced Pancreatitis Through Reduction of Fatty Acid Ethyl Ester-Induced Mitochondrial Injury and Necrotic Cell Death.
Journal: Pancreas
Published: December 05, 2017
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Journal: Brain : a journal of neurology
Published: April 24, 2015
Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury.
Journal: European journal of pharmacology
Published: December 22, 2014
Last Updated: 09/26/2026